Malawi is one of the many low income countries that can claim no substantive laboratory-based data on antimicrobial susceptibility. Laboratory surveillance of antimicrobial resistance is a prerequisite to guide informed selection and purchase of drugs for local use based on scientific proof. This is more cost effective and may lead to modification of treatment procedures as necessary.